Gleason Research Fellows
The Gleason Institute is proud to announce our four inaugural fellows. Each fellow received seed grants provided by the Health Sciences and Services Authority (HSSA) to promote new research into treatments, diagnostic tools and therapies for ALS and related neurodegenerative diseases.
Greg Carter, MD, MS
Carter is the Chief Medical Officer at Providence St. Luke’s Rehabilitation Medical Center and a clinical professor in the WSU Elson S. Floyd College of Medicine. His clinical and research interests include the use of cannabis to treat neuromuscular disorders. He has co-authored over 200 peer-reviewed journal articles along with multiple books and book chapters.
Naomi Chaytor, PhD
Chaytor is an associate professor in the Department of Medical Education and Clinical Sciences in WSU’s Elson S. Floyd College of Medicine. Her research focuses on cognition in adults with type 1 diabetes, including glycemic variability and cognitive performance, the relationships between cognitive performance and diabetes self-management behaviors, and cognitive, quality of life and emotional correlates of medical technology use.
Travis Denton, PhD
Denton is an assistant professor in the WSU College of Pharmacy and Pharmaceutical Sciences and is researching new drugs that target neurodegenerative disease.
Jason Gerstner, PhD
Gerstner is an assistant professor in WSU’s Elson S. Floyd College of Medicine and is developing new animal models of ALS and related diseases.